Acetaminophen-induced liver injury: From animal models to humans

Journal of Clinical and Translational Hepatology

Volumn 2, Issue 3, 2014, Pages 153-161

  Jaeschke, Hartmut ^a   Xie, Yuchao ^a   McGill, Mitchell R ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Drug hepatotoxicity; Necrosis, Sterile inflammation; Translational studies

Indexed keywords

EID: 84962570004     PISSN: 22250719     EISSN: 23108819     Source Type: Journal    
DOI: 10.14218/JCTH.2014.00014     Document Type: Review

References (109)

1. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005; 4:489–499. doi: 10.1038/nrd1750.
2. Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology 2014;146:914–928. doi: 10.1053/j.gastro.2013.12.032.
3. Uetrecht J, Naisbitt DJ. Idiosyncratic adverse drug reactions: current concepts. Pharmacol Rev 2013;65:779–808. doi: 10.1124/pr.113.007450.
4. Urban TJ, Shen Y, Stolz A, Chalasani N, Fontana RJ, Rochon J, et al. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet Genomics 2012;22:784–795. doi: 10.1097/FPC.0b013e3283589a76.
5. Budnitz DS, Lovegrove MC, Crosby AE. Emergency department visits for overdoses of acetaminophen-containing products. Am J Prev Med 2011;40: 585–592. doi: 10.1016/j.amepre.2011.02.026.
6. Lee WM. Acute liver failure. Semin Respir Crit Care Med 2012;33:36–45. doi: 10.1055/s-0032-1301733.
7. McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res 2013;30:2174–2187. doi: 10.1007/s11095-013-1007-6.
8. Srivastava A, Maggs JL, Antoine DJ, Williams DP, Smith DA, Park BK. Role of reactive metabolites in drug-induced hepatotoxicity. Handb Exp Pharmacol 2010;196:165–194. doi: 10.1007/978-3-642-00663-0_7.
9. Williams CD, Jaeschke H. Role of the innate and adaptive immunity during drug-induced liver injury. Toxicol Res 2012;1:161–170. doi: 10.1039/c2tx20032e.
10. Zaher H, Buters JT, Ward JM, Bruno MK, Lucas AM, Stern ST, et al. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol Appl Pharmacol 1998;152:193–199. doi: 10.1006/taap.1998.8501.
11. Raucy JL, Lasker JM, Lieber CS, Black M. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys 1989;271:270–283. doi: 10.1016/0003-9861(89)90278-6.
12. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973;187:211–217.
13. Cohen SD, Pumford NR, Khairallah EA, Boekelheide K, Pohl LR, Amouzadeh HR, et al. Selective protein covalent binding and target organ toxicity. Toxicol Appl Pharmacol 1997;143:1–12. doi: 10.1006/taap.1996.8074.
14. Tirmenstein MA, Nelson SD. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxicregioi-somer, 3'-hydroxyacetanilide, in mouse liver. J Biol Chem 1989;264:9814– 9819.
15. Meyers LL, Beierschmitt WP, Khairallah EA, Cohen SD. Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice. Toxicol Appl Pharmacol 1988;93:378–387. doi: 10.1016/0041-008X(88)90040-3.
16. Jaeschke H. Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J Pharmacol Exp Ther 1990;255:935–941.
17. Cover C, Mansouri A, Knight TR, Bajt ML, Lemasters JJ, Pessayre D, et al. Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity. J Pharmacol Exp Ther 2005; 315:879–887. doi: 10.1124/jpet.105.088898.
18. Kon K, Kim JS, Uchiyama A, Jaeschke H, Lemasters JJ. Lysosomal iron mobilization and induction of the mitochondrial permeability transition in acetaminophen-induced toxicity to mouse hepatocytes. Toxicol Sci 2010; 117:101–108. doi: 10.1093/toxsci/kfq175.
19. Kon K, Kim JS, Jaeschke H, Lemasters JJ. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 2004;40:1170–1179. doi: 10.1002/hep.20437.
20. Masubuchi Y, Suda C, Horie T. Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J Hepatol 2005; 42:110–116. doi: 10.1016/j.jhep.2004.09.015.
21. Ramachandran A, Lebofsky M, Baines CP, Lemasters JJ, Jaeschke H. Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury. Free Radic Res 2011;45:156–164. doi: 10.3109/10715762.2010.520319.
22. Knight TR, Ho YS, Farhood A, Jaeschke H. Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glu-tathione. J Pharmacol Exp Ther 2002;303:468–475. doi: 10.1124/jpet. 102.038968.
23. James LP, McCullough SS, Lamps LW, Hinson JA. Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. Toxicol Sci 2003;75:458–467. doi: 10.1093/toxsci/kfg181.
24. Saito C, Zwingmann C, Jaeschke H. Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology 2010;51:246–254. doi: 10.1002/hep.23267.
25. Fujimoto K, Kumagai K, Ito K, Arakawa S, Ando Y, Oda S, et al. Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen. Toxicol Pathol 2009;37:193–200. doi: 10.1177/0192623308329282.
26. Ramachandran A, Lebofsky M, Weinman SA, Jaeschke H. The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochon-drial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 2011;251:226–233. doi: 10.1016/j.taap.2011.01.004.
27. Jaeschke H, McGill MR, Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 2012;44:88–106. doi: 10.3109/03602532.2011.602688.
28. Bajt ML, Knight TR, Lemasters JJ, Jaeschke H. Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol Sci 2004;80:343–349. doi: 10.1093/toxsci/kfh151.
29. Hanawa N, Shinohara M, Saberi B, Gaarde WA, Han D, Kaplowitz N. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem 2008; 283:13565–13577. doi: 10.1074/jbc.M708916200.
30. Saito C, Lemasters JJ, Jaeschke H. c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 2010;246:8–17. doi: 10.1016/j.taap.2010.04.015.
31. Win S, Than TA, Han D, Petrovic LM, Kaplowitz N. c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J Biol Chem 2011;286:35071–35078. doi: 10.1074/jbc.M111.276089.
32. Gunawan BK, Liu ZX, Han D, Hanawa N, Gaarde WA, Kaplowitz N. c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 2006;131:165–178. doi: 10.1053/j.gastro.2006.03. 045.
33. Nakagawa H, Maeda S, Hikiba Y, Ohmae T, Shibata W, Yanai A, et al. Deletion of apoptosis signal-regulating kinase 1 attenuates acetamino-phen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology 2008;135:1311–1321. doi: 10.1053/j.gastro.2008.07. 006.
34. Shinohara M, Ybanez MD, Win S, Than TA, Jain S, Gaarde WA, et al. Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepato-toxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1. J Biol Chem 2010;285:8244–8255. doi: 10.1074/jbc.M109.054999.
35. Sharma M, Gadang V, Jaeschke A. Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity. Mol Pharmacol 2012;82:1001– 1007. doi: 10.1124/mol.112.079863.
36. Zhang YF, He W, Zhang C, Liu XJ, Lu Y, Wang H, et al. Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necrop-tosis during acetaminophen-evoked acute liver failure in mice. Toxicol Lett 2014;225:445–453. doi: 10.1016/j.toxlet.2014.01.005.
37. Ramachandran A, McGill MR, Xie Y, Ni HM, Ding WX, Jaeschke H. Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 2013;58:2099–2108. doi: 10.1002/hep.26547.
38. Wancket LM, Meng X, Rogers LK, Liu Y. Mitogen-activated protein kinase phosphatase (Mkp)-1 protects mice against acetaminophen-induced hepatic injury. Toxicol Pathol 2012;40:1095–1105. doi: 10.1177/0192623312447551.
39. Mobasher MA, González-Rodriguez A, Santamaría B, Ramos S, Martín MÁ, Goya L, et al. Protein tyrosine phosphatase 1B modulates GSK3β/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity. Cell Death Dis 2013;4:626. doi: 10.1038/cddis.2013.150.
40. Saberi B, Ybanez MD, Johnson HS, Gaarde WA, Han D, Kaplowitz N. Protein kinase C (PKC) participates in acetaminophen hepatotoxicity through c-jun-N-terminal kinase (JNK)-dependent and-independent signaling pathways. Hepatology 2014;59:1543–1554. doi: 10.1002/hep.26625.
41. Ray SD, Sorge CL, Raucy JL, Corcoran GB. Early loss of large genomic DNA in vivo with accumulation of Ca2+ in the nucleus during acetaminophen-induced liver injury.Toxicol Appl Pharmacol 1990;106:346–351. doi: 10.1016/0041-008X(90)90254-R.
42. Shen W, Kamendulis LM, Ray SD, Corcoran GB. Acetaminophen-induced cytotoxicity in cultured mouse hepatocytes: effects of Ca(2+)-endonu-clease, DNA repair, and glutathione depletion inhibitors on DNA fragmentation and cell death. Toxicol Appl Pharmacol 1992;112:32–40. doi: 10.1016/0041-008X(92)90276-X.
43. Bajt ML, Cover C, Lemasters JJ, Jaeschke H. Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury. Toxicol Sci 2006;94:217–225. doi: 10.1093/toxsci/kfl077.
44. Bajt ML, Ramachandran A, Yan HM, Lebofsky M, Farhood A, Lemasters JJ, et al. Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity. Toxicol Sci 2011;122:598–605. doi: 10.1093/toxsci/kfr116.
45. Bajt ML, Farhood A, Lemasters JJ, Jaeschke H. Mitochondrial bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity. J Pharmacol Exp Ther 2008;324: 8–14. doi: 10.1124/jpet.107.129445.
46. Cover C, Fickert P, Knight TR, Fuchsbichler A, Farhood A, Trauner M, et al. Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice. Toxicol Sci 2005; 84:201–208. doi: 10.1093/toxsci/kfi065.
47. Ni HM, Williams JA, Jaeschke H and Ding WX. Zonated induction of autophagy and mitochondrial spheroids limits acetaminophen-induced necrosis in the liver. Redox Biol 2013;1:427–432. doi: 10.1016/j.redox.2013.08.005.
48. Ni HM, Bockus A, Boggess N, Jaeschke H and Ding WX. Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology 2012;55:222–232. doi: 10.1002/hep.24690.
49. Ding WX, Guo F, Ni HM, Bockus A, Manley S, Stolz DB, et al. Parkin and mitofusins reciprocally regulate mitophagy and mitochondrial spheroid formation. J Biol Chem 2012; 287: 42379–42388. doi: 10.1074/jbc.M112.413682.
50. Ye D, Wang Y, Li H, Jia W, Man K, Lo CM, et al. FGF21 protects against acetaminophen-induced hepatotoxicity by potentiating PGC-1α-mediated antioxidant capacity in mice. Hepatology 2014; doi: 10.1002/hep.27060.
51. McCuskey RS. Sinusoidal endothelial cells as an early target for hepatic toxicants. Clin Hemorheol Microcirc 2006;34:5–10.
52. Walker RM, Racz WJ, McElligott TF. Acetaminophen-induced hepatotoxic congestion in mice. Hepatology 1985;5:233–240. doi: 10.1002/hep. 1840050213.
53. Lawson JA, Farhood A, Hopper RD, Bajt ML, Jaeschke H. The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 2000;54:509–516. doi: 10.1093/toxsci/54.2.509.
54. Ito Y, Bethea NW, Abril ER, McCuskey RS. Early hepatic microvascular injury in response to acetaminophen toxicity. Microcirculation 2003;10:391–400. doi: 10.1038/sj.mn.7800204.
55. Knight TR, Kurtz A, Bajt ML, Hinson JA, Jaeschke H. Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci 2001;62:212–220. doi: 10.1093/toxsci/62.2.212.
56. DeLeve LD, Wang X, Kaplowitz N, Shulman HM, Bart JA, van der Hoek A. Sinusoidal endothelial cells as a target for acetaminophen toxicity. Direct action versus requirement for hepatocyte activation in different mouse strains. Biochem Pharmacol 1997;53:1339–1345. doi: 10.1016/S0006-2952(97)00048-8.
57. Yin H, Cheng L, Holt M, Hail N Jr, Maclaren R, Ju C. Lactoferrin protects against acetaminophen-induced liver injury in mice. Hepatology 2010;51: 1007–1016. doi: 10.1002/hep.23476.
58. McGi l l MR, Wi l l i ams CD, Xi e Y, Ramachandran A, Jaeschke H. Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol 2012;264:387–394. doi: 10.1016/j.taap.2012.08.015.
59. Jaeschke H, Williams CD, McGill MR, Xie Y, Ramachandran A. Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products. Food Chem Toxicol 2013;55:279–289. doi: 10.1016/j.fct.2012.12.063.
60. Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet 1977;2:432–434. doi: 10.1016/S0140-6736(77)90612-2.
61. McGill MR, Sharpe MR, Williams CD, Taha M, Curry SC, Jaeschke H. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest 2012;122:1574–1583. doi: 10.1172/JCI59755.
62. McGill MR, Yan HM, Ramachandran A, Murray GJ, Rollins DE, Jaeschke H. HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology 2011;53:974–982. doi: 10.1002/hep.24132.
63. Xie Y, McGill MR, Dorko K, Kumer SC, Schmitt TM, Forster J, et al. Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. Toxicol Appl Pharmacol 2014; Jun 3. doi: 10.1016/j.taap.2014.05.010.
64. McGill MR, Lebofsky M, Norris HR, Slawson MH, Bajt ML, Xie Y, et al. Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. Toxicol Appl Pharmacol 2013;269:240–249. doi: 10.1016/j.taap.2013.03.026.
65. Larson AM. Acetaminophen hepatotoxicity. Clin Liver Dis 2007;11:525– 548. doi: 10.1016/j.cld.2007.06.006.
66. Lee KC, Palacios Jimenez C, Alibhai H, Chang YM, Leckie PJ, Baker LA, et al. A reproducible, clinically relevant, intensively managed, pig model of acute liver failure for testing of therapies aimed to prolong survival. Liver Int 2013;33:544–551. doi: 10.1111/liv.12042.
67. Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 2013;87:1315–1530. doi: 10.1007/s00204-013-1078-5.
68. Boess F, Kamber M, Romer S, Gasser R, Muller D, Albertini S, et al. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol Sci 2003; 73:386–402. doi: 10.1093/toxsci/kfg064.
69. LeCluyse E, Madan A, Hamilton G, Carroll K, DeHaan R, Parkinson A. Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. J Biochem Mol Toxicol 2000;14:177–188. doi: 10.1002/(SICI)1099-0461(2000)14:4<177::AID-JBT1>3.0.CO;2-4.
70. Anthérieu S, Chesné C, Li R, Guguen-Guillouzo C, Guillouzo A. Optimization of the HepaRG cell model for drug metabolism and toxicity studies. Toxicol In Vitro 2012;26:1278–1285. doi: 10.1016/j.tiv.2012.05.008.
71. Gerets HH, Tilmant K, Gerin B, Chanteux H, Depelchin BO, Dhalluin S, et al. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 2012; 28:69–87. doi: 10.1007/s10565-011-9208-4.
72. Van Summeren A, Renes J, Bouwman FG, Noben JP, van Delft JH, Kleinjans JC, et al. Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells. Toxicol Sci 2011;120:109–122. doi: 10.1093/toxsci/kfq380.
73. Manov I, Hirsh M, Iancu TC. N-acetylcysteine does not protect HepG2 cells against acetaminophen-induced apoptosis. Basic Clin Pharmacol Toxicol 2004;94:213–225. doi: 10.1111/j.1742-7843.2004.pto940504.x.
74. Dai Y, Cederbaum AI. Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells. J Pharmacol Exp Ther 1995;273:1497– 1505.
75. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003;125:1246–1257. doi: 10.1016/S0016-5085(03)01209-5.
76. Schattenberg JM, Galle PR, Schuchmann M. Apoptosis in liver disease. Liver Int 2006;26:904–911. doi: 10.1111/j.1478-3231.2006.01324.x.
77. Bajt ML, Lawson JA, Vonderfecht SL, Gujral JS, Jaeschke H. Protection against Fas receptor-mediated apoptosis in hepatocytes and nonparench-ymal cells by a caspase-8 inhibitor in vivo: evidence for a postmitochondrial processing of caspase-8. Toxicol Sci 2000;58:109–117. doi: 10.1093/toxsci/58.1.109.
78. Gujral JS, Knight TR, Farhood A, Bajt ML, Jaeschke H. Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci 2002;67:322–328. doi: 10.1093/toxsci/67.2.322.
79. Jaeschke H, Cover C, Bajt ML. Role of caspases in acetaminophen-induced liver injury. Life Sci 2006;78:1670–1676. doi: 10.1016/j.lfs.2005.07.003.
80. Schotte P, Declercq W, Van Huffel S, Vandenabeele P, Beyaert R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett 1999;442:117–121. doi: 10.1016/S0014-5793(98)01640-8.
81. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001; 61:1659–665.
82. Antoine DJ, Jenkins RE, Dear JW, Williams DP, McGill MR, Sharpe MR, et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol 2012;56:1070–1079. doi: 10.1016/j.jhep.2011. 12.019.
83. Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology 2012;143:1158–1172. doi: 10.1053/j.gastro.2012.09.008.
84. Jaeschke H, Williams CD, Ramachandran A, Bajt ML. Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int 2012;32:8–20. doi: 10.1111/j.1478-3231.2011. 02501.x.
85. Antoine DJ, Williams DP, Kipar A, Jenkins RE, Regan SL, Sathish JG, et al. High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo. Toxicol Sci 2009;112:521–531. doi: 10.1093/toxsci/kfp235.
86. Martin-Murphy BV, Holt MP, Ju C. The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice. Toxicol Lett 2010;192:387–394. doi: 10.1016/j.toxlet.2009.11.016.
87. Cover C, Liu J, Farhood A, Malle E, Waalkes MP, Bajt ML, et al. Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 2006;216:98–107. doi: 10.1016/j.taap.2006.04.010.
88. Holt MP, Cheng L, Ju C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol 2008; 84:1410–1421. doi: 10.1189/jlb.0308173.
89. Williams CD, Bajt ML, Farhood A, Jaeschke H. Acetaminophen-induced hepatic neutrophil accumulation and inflammatory liver injury in CD18-deficient mice. Liver Int 2010;30:1280–1292. doi: 10.1111/j.1478-3231.2010.02284.x.
90. Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, et al. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 2002;35: 289–298. doi: 10.1053/jhep.2002.30956.
91. McGill MR, Staggs VS, Sharpe MR, Lee WM, Jaeschke H. Acute Liver Failure Study Group. Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology 2014; Jun 13. doi: 10.1002/hep.27265.
92. James LP, Simpson PM, Farrar HC, Kearns GL, Wasserman GS, Blumer JL, et al. Cytokines and toxicity in acetaminophen overdose. J ClinPharmacol 2005;45:1165–1171. doi: 10.1177/0091270005280296.
93. Williams CD, Bajt ML, Sharpe MR, McGill MR, Farhood A, Jaeschke H. Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans. Toxicol Appl Pharmacol 2014;275:122–133. doi: 10.1016/j.taap.2014.01.004.
94. Antoniades CG, Quaglia A, Taams LS, Mitry RR, Hussain M, Abeles R, et al. Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology 2012;56:735–746. doi: 10.1002/hep.25657.
95. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213:286–300. doi: 10.1002/jcp.21172.
96. Fausto N. Liver regeneration and repair: Hepatocytes, progenitor cells, and stem cells. Hepatology 2004;39:1477–1487. doi: 10.1002/hep.20214.
97. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836–847. doi: 10.1038/nrm1489.
98. Kofman AV, Morgan G, Kirschenbaum A, Osbeck J, Hussain M, Swenson S, et al. Dose-and time-dependent oval cell reaction in acetaminophen-induced murine liver injury. Hepatology 2005;41:1252–1261. doi: 10.1002/hep.20696.
99. Chiu H, Gardner CR, Dambach DM, Durham SK, Brittingham JA, Laskin JD, et al. Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice. Toxicol Appl Pharmacol 2003;193:218–227. doi: 10.1016/j.taap.2003.07.003.
100. Bajt ML, Knight TR, Farhood A, Jaeschke H. Scavenging peroxynitrite with glutathione promotes regeneration and enhances survival during acetami-nophen-induced liver injury in mice. J Pharmacol Exp Ther 2003;307:67– 73. doi: 10.1124/jpet.103.052506.
101. Masubuchi Y, Bourdi M, Reilly TP, Graf ML, George JW, Pohl LR. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem Biophys Res Commun 2003;304:207–212. doi: 10.1016/S0006-291X(03)00572-2.
102. James LP, Lamps LW, McCullough S, Hinson JA.Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem Biophys Res Commun 2003;309:857–863. doi: 10.1016/j.bbrc.2003.08.085.
103. Donahower B, McCullough SS, Kurten R, Lamps LW, Simpson P, Hinson JA, et al. Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity. Am J Physiol Gastrointest Liver Physiol 2006;291: G102–109. doi: 10.1152/ajpgi.00575.2005.
104. Donahower BC, McCullough SS, Hennings L, Simpson PM, Stowe CD, Saad AG, et al. Human recombinant vascular endothelial growth factor reduces necrosis and enhances hepatocyte regeneration in a mouse model of acetaminophen toxicity. J Pharmacol Exp Ther 2010;334:33–43. doi: 10.1124/jpet.109.163840.
105. Thompson MD, Monga SP. WNT/beta-catenin signaling in liver health and disease. Hepatology 2007;45:1298–1305. doi: 10.1002/hep.21651.
106. Apte U, Singh S, Zeng G, Cieply B, Virji MA, Wu T, et al. Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury. Am J Pathol 2009;175:1056–1065. doi: 10.2353/ajpath.2009. 080976.
107. Taketa K. Alpha-fetoprotein: reevaluation in hepatology. Hepatology 1990; 12:1420–1432. doi: 10.1002/hep.1840120625.
108. Schmidt LE, Dalhoff K. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology 2005;41:26–31. doi: 10.1002/hep.20511.
109. Schiødt FV, Ostapowicz G, Murray N, Satyanarana R, Zaman A, Munoz S, et al. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl 2006;12:1776–1781. doi: 10.1002/lt.20886.